Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

1(50.0%)

N/A

1(50.0%)

2Total

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06403631Completed

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis

Role: collaborator

NCT06805734Recruiting

Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants

Role: collaborator

NCT07126353Not Yet Recruiting

Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism

Role: collaborator

NCT06472063Recruiting

Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study

Role: collaborator

NCT05614856Suspended

Aorto-iliac Occlusion Treatment With ShorT Unibody aorTic Endograft - ASTUTE Study

Role: collaborator

NCT03489603Completed

Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation Myocardial Infarction in Patients With Chest Pain in Emergency Departments in Italy-An Observational Study

Role: collaborator

NCT02273570Not ApplicableUnknown

Optimal Anemia Treatment in End Stage Renal Disease (ERSD)

Role: lead

NCT01923012Phase 2Unknown

Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis

Role: lead

NCT01956292Unknown

Continuous Monitoring of Blood Pressure in Spontaneous Intraparenchimal Cerebral Haemorrhage

Role: lead

All 9 trials loaded